NEWS

Haier Biomedical is proud to announce that a selection of its flagship products has successfully achieved certification under the European Union Medical Device Regulation (EU MDR 2017/745). This milestone underscores the company’s unwavering commitment to safety, performance, and full regulatory compliance across its product portfolio.

On March 19, HB TempCon Aviation, a subsidiary of Haier Biomedical, successfully passed the airworthiness review by the United States Federal Aviation Administration (FAA) for its independently developed Active Temperature Controlled RKN Container, becoming the first and only company in the Asia-Pacific region to receive an FAA Design Approval Letter (LODA) for an active temperature controlled container.

Haier Biomedical has successfully installed 100 HYC-61 smart vaccine refrigerators, 10 HYC-361 smart vaccine refrigerators, and 10 vaccine scanning cabinets across 10 hospitals and more than 10 township clinics in Nakhchivan, Azerbaijan. Equipped with IoT technology, this initiative creates a fully connected ecosystem, integrating people, equipment, and vaccines to build a smart vaccine city network. This ensures comprehensive vaccination safety while significantly advancing local healthcare infrastructure.

On March 7, following a successful product training and strategy session with the Australian partners, Haier Biomedical launched an intensive spring training program for its Southeast Asian distributors, concluding on a high note. The program provided in-depth insights into the company's cutting-edge products through a structured curriculum and practical workshops, enhancing distributors' knowledge and practical application of its solutions, thereby showcasing the company's strong organizational capabilities and commitment to global service excellence.

The management of fentanyl and other controlled substances has long been a critical global issue in medical safety. Recently, global attention on fentanyl control has intensified, fueling discussions on effective strategies for managing these high-risk drugs.

Recently, Haier Biomedical has achieved a new milestone in the higher education sector of Hong Kong and Macau with the successful installation of its first batch of centrifuges at Macau University of Science and Technology (MUST). The company's centrifuges have already been adopted by prestigious institutions, including the University of Hong Kong and the Hong Kong Polytechnic University.

In the biopharmaceutical industry, the transport and storage of temperature-sensitive biosamples and pharmaceuticals—such as blood products, cells, biological tissues, and vaccines—require a consistently stable ultra-low temperature environment to maintain their viability and integrity. This demands exceptional insulation performance and reliability from transport equipment. Recently, Haier Biomedical's CryoBio Biobank Series Liquid Nitrogen Container and Low-Temperature Transport Trolley have gained significant recognition in the Japanese market, earning widespread praise and strong user preference.

Haier Biomedical's Incubator Agitator for Platelet was recently installed and put into operation at Union Hospital in Hong Kong, China. This marks yet another significant milestone, showcasing the strong market acceptance and recognition of Haier Biomedical’s technology in the high-end medical sector.

Haier Biomedical Super Energy-Saving ULT Freezer - Designed to provide long-term storage for various biological samples and sensitive items to ensure the integrity and stability of precious materials.